LOGIT WORKING PAPER No 1309 APRIL 2026
MEASUREMENT IN HEALTH TECHNOLOGY ASSESSMENT
THE TRANSITION TO REPRESENTATIONAL MEASUREMENT IN HEALTH TECHNOLOGY ASSESSMENT: THE EUROPEAN UNION
GERMANY: FROM MEASUREMENT INVERSION TO ADMISSIBLE CLAIMS IN THERAPY IMPACT ASSESSMENT
Paul C Langley PhD Adjunct Professor, College of Pharmacy, University of Minnesota, Minneapolis, MN
